Advertisement

Topics

Sekisui Diagnostics Company Profile

10:22 EDT 25th May 2017 | BioPortfolio

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices throughout the world. Formerly known as Genzyme Diagnostics, Sekisui Diagnostics has over 30 years of experience developing, manufacturing and commercializing a variety of unique products which meet the needs of the global diagnostics market. Learn more about Sekisui Diagnostics at www.sekisuidiagnostics.com.


News Articles [851 Associated News Articles listed on BioPortfolio]

Sekisui Diagnostics launches bacterial vaginosis rapid test in Europe, Middle East and North Africa

Global diagnostics firm Sekisui Diagnostics has introduced OSOM BVBLUE test in Europe, Middle East and North Africa.

Sekisui Diagnostics Announces Launch of OSOM® BVBLUE® Rapid Test for Bacterial Vaginosis in Europe, Middle East and North Africa

LEXINGTON, Mass., Jan. 11, 2017 /PRNewswire/ -- Today, Sekisui Diagnostics announces the launch of the OSOM® BVBLUE® Test in Europe, Middle East and North Africa.  The OSOM® BVBLUE® Test, whi...

Sekisui XenoTech adds new test systems to service offerings

Sekisui XenoTech has added new dermal subcellular fraction test systems to its contract research services.

Sekisui XenoTech Adds New Dermal Subcellular Fraction Test Systems

  Life Sciences Jobs   ...

Global Influenza Diagnostics Market 20172021 [Updated: 13032017] Prices from USD $3500

About Influenza DiagnosticsThe global influenza diagnostics market is expected to grow at a moderate pace in the forecast period. The factors that are expected to drive the market in the forecast peri...

The Top 100 Manufacturers Of IVD Reagents, Instruments & Accessories Worldwide

LONDON, Jan. 16, 2017 /PRNewswire/ -- Did you know?- Transasia Bio-Medicals is India's largest in-vitro diagnostic company.- Nova Biomedical is the largest privately owned in-vitro diagnostic company ...

2017 Thermo Fisher: Diagnostics Sales, Market Shares and Competitive Position by Product and Country [Updated: 23032017] Prices from USD $4250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Thermo Fisher Competitive Position, Sales and Market Shares by Country and Product Prices from USD $4250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [256 Associated PubMed Articles listed on BioPortfolio]

Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

In recent years, the private and public sectors have increased investments in medical diagnostics for low- and middle-income countries (LMICs). Despite these investments, numerous barriers prevent the...

Resistance diagnosis and the changing economics of antibiotic discovery.

Point-of-care diagnostics that can determine an infection's antibiotic sensitivity increase the profitability of new antibiotics that enjoy patent protection, even when such diagnostics reduce the qua...

Next-Generation Sequencing in Cancer Diagnostics.

This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.

Current position of diagnostics and surgical treatment for upper tract urothelial carcinoma.

The applicability of urinary biomarkers and optical diagnostics in upper urinary tract carcinoma (UUTUC) are increasingly debated. To receive insight in the opinion of the urological community involve...

Point-of-Care Diagnostics for Improving Maternal Health in South Africa.

Improving maternal health is a global priority, particularly in high HIV-endemic, resource-limited settings. Failure to use health care facilities due to poor access is one of the main causes of mater...

Clinical Trials [143 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions

The "Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT)" represents a mono-centric registry of patients being hospitalized su...

Companies [881 Associated Companies listed on BioPortfolio]

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (www.erbadiagnostics.com), headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distrib...

More Information about "Sekisui Diagnostics" on BioPortfolio

We have published hundreds of Sekisui Diagnostics news stories on BioPortfolio along with dozens of Sekisui Diagnostics Clinical Trials and PubMed Articles about Sekisui Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sekisui Diagnostics Companies in our database. You can also find out about relevant Sekisui Diagnostics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record